In this issue of PET Clinics, guest editors Drs. Cristina Nanni, Paolo Castellucci, Stefano Fanti, and Neeta Pandit-Taskar bring their considerable expertise to the topic of Novel PET Imaging Techniques in the Management of Hematological Malignancies. Top experts in the field discuss the latest radiotracers for lymphoma and myeloma, novel quantitative imaging techniques, radioligand therapies, total body PET imaging; and more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. CME Accreditation Page - p. xi 8. Preface - p. xiii 9. 2-deoxy-2-[18F]FDG PET Imaging for Therapy Assessment in Hodgkin’s and Non-Hodgkin Lymphomas - p. 447 10. New PET Tracers for Lymphoma - p. 463 11. Radioligand Therapy in Lymphoma: Past, Present, and Future - p. 475 12. Long-Axial Field-of-View PET Imaging in Patients with Lymphoma: Challenges and Opportunities - p. 495 13. FDG-PET/CT Imaging in Chimeric Antigen Receptor–Engineered T-Cell Treatment in Patients with B-Cell Lymphoma: Current Evidence - p. 505 14. New PET Tracers for Symptomatic Myeloma - p. 515 15. Symptomatic Myeloma: PET, Whole-Body MR Imaging with Diffusion-Weighted Imaging or Both - p. 525 16. Applications of 18F-Fluorodesoxyglucose PET Imaging in Leukemia - p. 535 17. Role of Novel Quantitative Imaging Techniques in Hematological Malignancies - p. 543 18. Lymphoma: The Added Value of Radiomics, Volumes and Global Disease Assessment - p. 561 19. PET Imaging in Chimeric Antigen Receptor T-Cell Trafficking - p. 569
In this issue of PET Clinics, guest editors Drs. Cristina Nanni, Paolo Castellucci, Stefano Fanti, and Neeta Pandit-Taskar bring their considerable expertise to the topic of Novel PET Imaging Techniques in the Management of Hematological Malignancies. Top experts in the field discuss the latest radiotracers for lymphoma and myeloma, novel quantitative imaging techniques, radioligand therapies, total body PET imaging; and more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. CME Accreditation Page - p. xi 8. Preface - p. xiii 9. 2-deoxy-2-[18F]FDG PET Imaging for Therapy Assessment in Hodgkin’s and Non-Hodgkin Lymphomas - p. 447 10. New PET Tracers for Lymphoma - p. 463 11. Radioligand Therapy in Lymphoma: Past, Present, and Future - p. 475 12. Long-Axial Field-of-View PET Imaging in Patients with Lymphoma: Challenges and Opportunities - p. 495 13. FDG-PET/CT Imaging in Chimeric Antigen Receptor–Engineered T-Cell Treatment in Patients with B-Cell Lymphoma: Current Evidence - p. 505 14. New PET Tracers for Symptomatic Myeloma - p. 515 15. Symptomatic Myeloma: PET, Whole-Body MR Imaging with Diffusion-Weighted Imaging or Both - p. 525 16. Applications of 18F-Fluorodesoxyglucose PET Imaging in Leukemia - p. 535 17. Role of Novel Quantitative Imaging Techniques in Hematological Malignancies - p. 543 18. Lymphoma: The Added Value of Radiomics, Volumes and Global Disease Assessment - p. 561 19. PET Imaging in Chimeric Antigen Receptor T-Cell Trafficking - p. 569
